Literature DB >> 1845807

Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture.

K D Croen1, J M Ostrove, L Dragovic, S E Straus.   

Abstract

The ability of herpes simplex virus type 2 (HSV-2) to establish latency in and reactivate from sacral dorsal root sensory ganglia is the basis for recurrent genital herpes. The expression of HSV-2 genes in latently infected human sacral ganglia was investigated by in situ hybridization. Hybridizations with a probe from the long repeat region of HSV-2 revealed strong nuclear signals overlying neurons in sacral ganglia from five of nine individuals. The RNA detected overlaps with the transcript for infected cell protein O but in the opposite, or "anti-sense," orientation. These observations mimic those made previously with HSV-1 in human trigeminal ganglia and confirm the recent findings during latency in HSV-2-infected mice and guinea pigs. Northern hybridization of RNA from infected Vero cells showed that an HSV-2 latency-associated transcript was similar in size to the larger (1.85 kb) latency transcript of HSV-1. Thus, HSV-1 and HSV-2 latency in human sensory ganglia are similar, if not identical, in terms of their cellular localization and pattern of transcription.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845807     DOI: 10.1093/infdis/163.1.23

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Localization of cis-acting sequence requirements in the promoter of the latency-associated transcript of herpes simplex virus type 1 required for cell-type-specific activity.

Authors:  A H Batchelor; P O'Hare
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Mutations in the 5' end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes.

Authors:  K Wang; L Pesnicak; S E Straus
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

4.  Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus.

Authors:  M F Kramer; D M Coen
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 5.  Herpes latency, meningitis, radiculomyelopathy and disseminated infection.

Authors:  J J Sasadeusz; S L Sacks
Journal:  Genitourin Med       Date:  1994-12

6.  Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Authors:  Christine Johnston; Jia Zhu; Lichen Jing; Kerry J Laing; Christopher M McClurkan; Alexis Klock; Kurt Diem; Lei Jin; Jeffrey Stanaway; Elizabeth Tronstein; William W Kwok; Meei-Li Huang; Stacy Selke; Youyi Fong; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Analysis of the promoter and cis-acting elements regulating expression of herpes simplex virus type 2 latency-associated transcripts.

Authors:  K Wang; P R Krause; S E Straus
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 8.  Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology.

Authors:  Melvyn J Ball; Walter J Lukiw; Eli M Kammerman; James M Hill
Journal:  Alzheimers Dement       Date:  2012-11-14       Impact factor: 21.566

9.  Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.

Authors:  Karen E Mark; Anna Wald; Amalia S Magaret; Stacy Selke; Laura Olin; Meei-Li Huang; Lawrence Corey
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

10.  The nucleotide sequence, 5' end, promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency-associated transcript.

Authors:  P R Krause; J M Ostrove; S E Straus
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.